Sunitinib-induced complete response in metastatic renal cancer expressing neuroendocrine markers: A new predictive factor?

Donatella Gambini, Elisa Locatelli, Umberto Gianelli, Claudia Bareggi, Barbara Galassi, Roberto Visintin, Sara Massironi, Paolo G. Dell'orto, Maurizio Tomirotti

Research output: Contribution to journalArticle

Abstract

Background: To date, no predictive factors are recognized and applied in the therapeutic choice for metastatic renal cell carcinoma. Due to significant sideeffects and costs, which are relevant issues in this setting, optimization of treatments has become a priority. Case Report: We herein report a case of complete remission of metastatic renal cell carcinoma after 1 year of treatment with sunitinib. Since pancreatic metastases were detected by a 68Ga-DOTA-NOC positron emission tomography, it was decided to perform a histological revision of the specimens, with immunohistochemical staining for neuroendocrine markers on the primary tumor. Conclusion: On the basis of the detection of neuroendocrine markers on the primary neoplasm, together with pancreatic metastases positive on a 68Ga-DOTA-NOC positron emission tomography (PET), we hypothesize and discuss about a potential role of specific neuroendocrine markers as predictive indicators of response to sunitinib (and allegedly to other target therapies) in the treatment of this neoplasm.

Original languageEnglish
Pages (from-to)7361-7365
Number of pages5
JournalAnticancer Research
Volume34
Issue number12
Publication statusPublished - Dec 1 2014

Keywords

  • Neuroendocrine markers
  • Predictive markers
  • Renal cell carcinoma
  • Sunitinib

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Fingerprint Dive into the research topics of 'Sunitinib-induced complete response in metastatic renal cancer expressing neuroendocrine markers: A new predictive factor?'. Together they form a unique fingerprint.

  • Cite this

    Gambini, D., Locatelli, E., Gianelli, U., Bareggi, C., Galassi, B., Visintin, R., Massironi, S., Dell'orto, P. G., & Tomirotti, M. (2014). Sunitinib-induced complete response in metastatic renal cancer expressing neuroendocrine markers: A new predictive factor? Anticancer Research, 34(12), 7361-7365.